Over the past two years, the cancer in Russia has begun significantly more often to buy medicines for their money. This is stated in the study of the sectoral publication “Pharmaceutical Bulletin” and Alpharm, which refers to “Vedomosti”.
If in 2018, 2.2 billion rubles spent on such purchases in pharmacies, which in the 2020th – already 5.2 billion. The situation began to change in 2019, when the indicator jumped to 4.1 billion rubles.
In the same year, the implementation of the program of the National Project “Health” began. Together with additional financing of purchasing drugs, so that patients can receive them for free, the share of products of Russian companies increased. It did not fully correspond to the market expectations.
If there are 63.7 percent in state transportations to Russian drugs, then in pharmacies – only 26 percent. Director for the Development of the Association of Oncologists of Russia Babodur Kamolov pointed out that the state, as a rule, prefers cheap Russian generics, inferior in quality with original foreign drugs or foreign analogues.
As statistics are displayed, patients themselves, meanwhile, prefer foreign medicine.
According to Kamolov, in his practice there was not one case when after treatment the patient received a generic and encountered a recurrence. Russian companies are used in the production of Indian and Chinese substances, the quality of which is not always satisfactory.
At the end of 2019, specialists of NMIC oncology named after Blokhin complained to the Ministry of Health on the problems of Russian drugs for antitumor and accompanying therapy of children. Then the department essentially ignored the appeal.
In the past, private clinics on the CHA program could have been assisted in the past, the doctors purchased high-quality medicines. From 2021 this practice is canceled.
Earlier it was reported that the production of drugs in Russia in January-February 2021 increased by 61 percent in ruble equivalent, up to 101.4 billion rubles. Meanwhile, revenue of Russian pharmaceutical networks from the beginning of the year fell by 12 percent – up to 331.6 billion rubles.